资讯

TierPoint, a leading, national enterprise data center company and provider of secure, connected IT platform solutions that power digital transformation initiatives, today announced the completion of a ...
Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.
Oregon State University researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, ...